Jun 15, 2018 8:30 am EDT Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
Jun 11, 2018 5:30 am EDT Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules
Mar 6, 2018 5:30 am EST Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health
Mar 1, 2018 4:30 pm EST Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
Feb 20, 2018 5:30 am EST Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study
Jan 24, 2018 5:30 am EST Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories
Nov 28, 2017 5:30 am EST Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation